Infectious Disease CME

Antimicrobial resistance (AMR) is a phenomenon fueled by the selection pressure leveled against microorganisms through the use and misuse of antimicrobials in clinical and agricultural settings as well as horizontal gene transfer between pathogens. The WHO predicts that there will be 50 million deaths caused by infectious diseases, and the U.N. General Assembly has designated the emergence of AMR the largest world health problem.

The World Health Assembly has endorsed a Global Action Plan on Antimicrobial Resistance, including one step to address AMR: the sustainable investment in and development of new antimicrobials. Helping the clinician discern the role of these advances merits continuing healthcare professional education, as research suggests that HCPs are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice. In so doing, the goal is to educate clinicians about the appropriate role of novel antibiotics so that they may more effectively address the challenge of AMR rather than contributing to it.

Target Audience:

HCPs specializing in: Infectious disease, critical care, and primary care; physician assistants, nurse practitioners, nurses, and pharmacists who practice in the aforementioned areas of specialty; and any other healthcare professionals with an interest in or who treat patients with antimicrobials.

By the end of the session the participant will be able to:

• Identify key findings from the ID Week 2019 conference.
• Apply the changes in CAP guidelines 2019 from 2007.
• Identify novel drugs approved in 2019 and their potential.
• Understand the implications of some current research and paradigm shifts.
• Review HIV progress in the last year.

Contains seven disease-based interactive modules:
Chlamydia, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Pelvic inflammatory Disease (PID), Syphilis and Vaginitis.

Target Audience:
Physicians focusing on Family Medicine, Internal Medicine, OB-GYN, Infectious Disease

After login, Choose “Search.” You may then search for courses by date, keyword, or display all. Searching keyword “Web on Demand” will bring you to a list of online courses on public health and preventive medicine topics with an emphasis on vaccination.

Target Audience: Physicians focusing on Preventive Medicine, Infectious Disease

This site offers numerous brief presentations concerning Hepatitis B (HBV), Hepatitis C (HBC), Hepatic Encephalopathy (HE) and Hepatocellular Carcinoma (HCC).

Target Audiences:
Hepatology, Gastroenterology and any medical professional who serves patients with chronic liver disease.

About 17 text-based or case-based-interactive activities concerned with aspects of Hepatitis B and Hepatitis C infection.

All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Recent presentations include:
• Highlights From Amsterdam 2013: HCV Phase III Studies and Approved Agents
• Management of Chronic Hepatitis B Virus Infection in Women of Reproductive Age
• Hepatitis Highlights
• So You Think You’re a Hepatitis C Expert, Educational Material, Part 3
• Updates in Viral Hepatitis from AASLD 2012
• Treat or Wait in HCV? A Series of Challenging Case Vignettes

Target Audience: Physicians focusing on Infectious Disease and related specialties.

About 16 text-based or case-based-interactive activities concerned with aspects of HIV infection and AIDS.

All of these categories offer CME credit:
Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Topics include:
• Practical Strategies to Engage HIV Patients in Timely Care
• HIV Highlights
• Highlights of Atlanta 2013: ART as Treatment and Prevention
• Highlights of Atlanta 2013: Coinfections and Comorbidities
• Understanding and Addressing Cultural and Socioeconomic Barriers to Effective HIV Management
• Highlights of Glasgow 2012: CCO Independent Conference Coverage of the 2012 International Congress on Drug Therapy in HIV Infection

Target Audience: Physicians focusing on Infectous Disease

A set of brief (30 minutes) case simulations about:
• Hepatitis A (3)
• Hepatitis B (14)
• Hepatitis C (6)
• Common Management Issues (2) and
• Health Educator (2).

Target Audience: Physicians focusing on Family Medicine, Internal Medicine, and Infectious Disease

Experts present the latest data and insights on HIV, plus case discussions on:
• Optimizing management of patients with HIV infection based on recent developments
• Understanding successful methods to prevent HIV infection and the limitations impeding their widespread implementation
• Diagnosis and management of important comorbidities occurring in persons with HIV infection
• Antiretroviral management at all disease stages.

Target Audience:
Infectious Disease and other healthcare professionals involved in HIV treatment and care.

Site contains over 70 half-credit modules concerning diagnosis and treatment of HIV/AIDS.

Topics include:
Initial Evaluation; Dermatologic Manifestations; Oral Manifestations; Opportunistic Infections: Prophylaxis; Opportunistic Infections: Treatment; Antiretroviral Rx; Antiretroviral Rx: Resistance; Antiretroviral Rx: Adverse Effects; Drug-Drug Interactions; Postexposure Prophylaxis; Perinatal Transmission; Special Populations, Prevention for Positives, and Challenging Unknowns.

You will also find 3 interactive tutorials: Routine HIV Screening; Oraquick Advance Rapid HIV Test; and HIV Integration (probably one hour each).

Target Audience: Physicians specializing in Infectious Diesase.

Increasing Awareness of Hansen’s Disease in the United States is designed to increase health care providers’ awareness of this unique and misunderstood disease.

The course consists of two separate lectures: The first lecture covers introductory topics and concepts that are necessary to understand how Hansen’s Disease is diagnosed and treated. The second lecture covers more advanced treatment topics and concepts.

Completing this course will enable you to:
• Access the services provided by the National Hansen’s Disease Programs to healthcare providers;
• Recognize the cardinal signs and symptoms of Hansen’s disease;
• Understand the microbiology and pathology of Hansen’s Disease before and after treatment;
• Identify the varied clinical presentations of Hansen’s disease;
• List two basic treatment regimens used in the U.S. for Hansen’s disease and how patients are classified into these two groups; and
• Learn the complications of Hansen’s disease and how to manage them.

To enroll, call 1-800-642-2477 or send an E-mail to [email protected] Once enrolled, all modules and post-tests must be completed within 2 weeks.

Target Audiences: Physicians specializing in Dermatology, Neurology, ER, Family Medicine, and Public Health